VCEL

Insider Trades

Name	Value	Action	Price	Current Price
Hopper Jonathan MarkChief Medical Officer $153k4.4k shares SellJun 2, 2026 $35.00 --
Mclaughlin Kevin FDirector $115k3.5k shares SellMay 13, 2026 $32.83 --
Mclaughlin Kevin FDirector $115k3.5k shares SellMay 13, 2026 $32.82 --
Wotton Paul KDirector $245k7.5k shares SellMay 11, 2026 $32.64 --
Wotton Paul KDirector $83k2.5k shares SellMay 11, 2026 $33.05 --
Mara Joseph Anthony JrChief Financial Officer $203k5k shares SellMay 7, 2026 $40.50 --

News

globenewswire.comVericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026globenewswire.comJun 9

fool.comVericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million Morefool.comMay 30

marketbeat.comVericel Q1 Earnings Call Highlightsmarketbeat.comMay 9

seekingalpha.comVericel Corporation (VCEL) Q1 2026 Earnings Call Transcriptseekingalpha.comMay 7

zacks.comVericel Corporation (VCEL) Reports Q1 Loss, Beats Revenue Estimateszacks.comMay 7

Trade VCEL

About Vericel Corporation

Vericel Corporation operates as a biopharmaceutical firm that has reached the commercialization phase, specializing in the research, development, production, and distribution of cell-based treatments. Its primary therapeutic areas are sports medicine and critical burn care across the United States. The company's product lineup includes MACI, an autologous cellularized scaffold employed for mending symptomatic, full-thickness cartilage damage in the knee, and Epicel, a permanent skin replacement designated as a humanitarian use device for treating deep-dermal or full-thickness burns in both adults and children. Additionally, Vericel is progressing NexoBrid, an orphan biological product currently in the registration phase, which aims to remove eschar from deep partial-thickness or full-thickness thermal burns in adults. Established in 1989 under its former name, Aastrom Biosciences, Inc., the company is headquartered in Cambridge, Massachusetts.

CEO: Dominick C. Colangelo
IPO Date: Feb 4, 1997

Market Data

Open: $40.04
High: $40.60
Low: $38.98
Volume: 1.4M
Avg Volume: 660.1K
52W High: $43.57
52W Low: $28.95

Valuation

Market Cap: $2.0B
Enterprise Value: $2.0B
Dividend Yield: 0.00%

Financials

Free Cash Flow: $25M
Revenue: $276M
Net Income: $17M
Cash: $100M
Debt: $98M

Events

EarningsJul 30

EPS est. -0.04